Delivering specialist storage solutions for the medical cannabis market

All pharmaceutical products require appropriate temperature storage to preserve their potency.  Most products require 15–25°C  with some products requiring refrigerated storage between 2–8°C.

To grow and process cannabis plants in Australia requires federal and state licenses, and dependent on how the product is presented, it will appear in Schedule 4, 8 or 9.

At BS3 we provide:

  • Specialty temperature-controlled storage solutions & distribution for Schedule Medicines and products that fall under licenses for 2, 3, 4, 8 and 9 pharmaceutical products.
  • Schedule 8 refrigerated storage options at 2–8°C.
  • General temperature-controlled storage facilities where the storage requirement is between 15-25°C.
  • Large secure vaulted storage facilities with video surveillance specifically required to store S8 and S9 products.
  • Specialist S8 waste handling and storage management.
  • Specialized legal compliance knowledge is required for all Scheduled Medicines.
  • The highly specialized transportation capabilities are necessary to distribute Scheduled Medicines.

Meeting the specialist required for medical cannabis scheduled medicines

At BS3 we will support you with the expertise and storage solutions required to meet the needs of each schedule.

  • Schedule 4 products containing only cannabidiol (CBD) require a basic security storage control.
  • Products that contain Tetrahydrocannabinol (THC) and derivatives and products that include Dronabinol and Nabiximol, are generally Schedule 8  therefore, requiring a more specialty, robust storage solution that adheres to the strict legal necessary requirements of safe or vaulted storage with video security.
  • Additionally, some cannabis Schedule 8 product requires refrigerated secure vaulted storage at 2–8°C.

Providing the expertise essential for all areas of medical cannabis storage

Our expertise extends right through to the storage and handling of Schedule 8 and 9 medical product manufacturing waste awaiting the strictly regulated destruction process.

The regulatory (EPA/TGA) compliant destruction lead time can take up to 6 – 8 months, creating overflow storage and handling challenges for many pharmaceutical manufacturers requiring ongoing waste destruction.

BS3’s Melbourne storage facility also caters to the growing demand for handling and storage of highly regulated Schedule 8 and 9 material waste.

With the appropriate licenses and extensive regulatory expertise, BS3 is equipped to meet the requirements of schedule 2, 3, 4, 8 & 9 materials across all areas from safe and vaulted storage, temperature control storage, security, handling, and distribution through to waste product handling and storage.

How can we help you? Contact BS3 today.